These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1650549)

  • 1. Differences in fusogenicity and mouse neurovirulence of Japanese encephalitis viruses.
    Higgs S; Gould EA
    Arch Virol; 1991; 119(1-2):119-33. PubMed ID: 1650549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies.
    Kimura-Kuroda J; Yasui K
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants.
    Cecilia D; Gould EA
    Virology; 1991 Mar; 181(1):70-7. PubMed ID: 1704661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the phenotypic characteristics of Japanese encephalitis virus strains isolated from different years].
    Liu XY; Yu YX; Li MG; Xu HS; Wang HY; Liang GD; Jia LL; Dong GM
    Bing Du Xue Bao; 2008 Nov; 24(6):427-31. PubMed ID: 19226950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness.
    Ni H; Barrett AD
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1449-55. PubMed ID: 8757986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on persistent infection of Japanese encephalitis virus Beijing-1 strain in serum-free Sf9 cell cultures.
    Kim H; Lee SJ; Park JY; Park YW; Kim HS; Kang HY; Hur BK; Ryu YW; Han SI; Kim JS
    J Microbiol; 2004 Mar; 42(1):25-31. PubMed ID: 15357288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice.
    Hasegawa H; Yoshida M; Shiosaka T; Fujita S; Kobayashi Y
    Virology; 1992 Nov; 191(1):158-65. PubMed ID: 1329314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).
    Arroyo J; Guirakhoo F; Fenner S; Zhang ZX; Monath TP; Chambers TJ
    J Virol; 2001 Jan; 75(2):934-42. PubMed ID: 11134306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice.
    Chambers TJ; Jiang X; Droll DA; Liang Y; Wold WSM; Nickells J
    J Gen Virol; 2006 Nov; 87(Pt 11):3131-3140. PubMed ID: 17030845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial role of a nonpathogenic orbi-like virus: studies on the interfering effect of M14 virus in mice and mosquitoes infected with Japanese encephalitis virus.
    Huang CH; Liang HC; Jia FL
    Intervirology; 1985; 24(3):147-53. PubMed ID: 2999029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Persistence of Japanese encephalitis virus clones in continuous HeLa cells].
    Cherednichenko IuN
    Vopr Virusol; 1982; 27(2):203-7. PubMed ID: 6283742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the biological and genetic characteristics of a highly neurovirulent Japanese encephalitis virus strain SA4].
    Liu XY; Yu YX; Yue GZ; Yang LH; Jia LL; Dong GM
    Bing Du Xue Bao; 2010 Jul; 26(4):265-70. PubMed ID: 20836378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic analysis of Japanese encephalitis virus by using monoclonal antibodies.
    Kobayashi Y; Hasegawa H; Oyama T; Tamai T; Kusaba T
    Infect Immun; 1984 Apr; 44(1):117-23. PubMed ID: 6200438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.
    Srivastava AK; Putnak JR; Lee SH; Hong SP; Moon SB; Barvir DA; Zhao B; Olson RA; Kim SO; Yoo WD; Towle AC; Vaughn DW; Innis BL; Eckels KH
    Vaccine; 2001 Aug; 19(31):4557-65. PubMed ID: 11483284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants.
    Ni H; Barrett AD
    Virology; 1998 Feb; 241(1):30-6. PubMed ID: 9454714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic characterization of nine wild-type Taiwanese isolates of Japanese encephalitis virus as compared with two vaccine strains.
    Wu SC; Lian WC; Hsu LC; Wu YC; Liau MY
    Virus Res; 1998 May; 55(1):83-91. PubMed ID: 9712514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus isolations from mosquitoes collected during the 1982 Japanese encephalitis epidemic in northern Thailand.
    Leake CJ; Ussery MA; Nisalak A; Hoke CH; Andre RG; Burke DS
    Trans R Soc Trop Med Hyg; 1986; 80(5):831-7. PubMed ID: 2885948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.